We store cookies on your device to make sure we give you the best experience on this website. I'm fine with this - Turn cookies off
Switch to an accessible version of this website which is easier to read. (requires cookies)

Protecting the NHS

November 28, 2019 12:26 PM

A damning poll has revealed that a
majority of people do not believe
Boris Johnson's promise to keep
the NHS out of a trade deal with
Donald Trump after Brexit. The
poll by Survation found only 31%
believe his pledge on the NHS and
a US trade deal. How safe is the
NHS from Brexit, privatisation and
US Drug Giants?

In 2013 the Conservative Health
Secretary privatised Plasma
Resources UK, the blood plasma
supplier NHS patients rely on. It
was sold for £200m to a US private
equity group, Bain Capital. Bain
promised to invest in the company
to make it a "life sciences
champion". Instead they sold it to
a Chinese company just three years
later for a cool £820 million. The
Conservative Government did not
If we leave the EU, Boris Johnson
has made getting a trade deal with
the US a priority. US drugs
companies are demanding "full
market Access" to the NHS' £80m
annual drugs' spending. At the
moment drugs in the US cost nearly
six times as much as the same drug
sold to the NHS.

The NHS has just published its
highest ever vacancy levels for
nurses. With 43,000 nursing roles
unfilled there is a shortage in most
NHS Trusts. Since the 2016 Brexit
vote nearly 5000 nurses have
returned home to their EU
In 2017 the Conservatives cut
bursaries for trainee nurses. Since
then applications have declined
significantly. After years of
underfunding Boris Johnson says
the NHS is safe in his hands.
Evidence suggests the opposite.